Conference item icon

Conference item

Glucosidase inhibitors induce HCV glycoproteins misfolding, impair viral assembly and release, and reduce the infectivity of residually secreted HCV particles

Abstract:
Novel anti-HCV molecules are still needed to better combat HCV infection. Molecules targeting specifically viral activities are the most attractive in terms of drug development and are therefore the most studied. The antiviral properties of glucosidase inhibitors were established using the most relevant models currently available.
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Publisher copy:
10.1002/hep.21395

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Biochemistry
Role:
Author
Expand authors...
Publisher:
Wiley Publisher's website
Volume:
44
Issue:
4
Pages:
198A-198A
Host title:
57th Annual Meeting of the American Association for the Study of Liver Diseases
Publication date:
2006-10-01
DOI:
EISSN:
1527-3350
ISSN:
0270-9139
Source identifiers:
100492
Pubs id:
pubs:100492
UUID:
uuid:133cb2f7-ea3e-422a-b547-5b1491b7c587
Local pid:
pubs:100492
Deposit date:
2012-12-19

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP